Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Feb 7;11(2):e4024.
doi: 10.7759/cureus.4024.

Tumor Lysis Syndrome: A Rare Complication of Chemotherapy for Metastatic Breast Cancer

Hafiz M Aslam  1 , Cassandra Zhi  2 , Sara L Wallach  3
Affiliations
Case Reports

Tumor Lysis Syndrome: A Rare Complication of Chemotherapy for Metastatic Breast Cancer

Hafiz M Aslam et al. Cureus. .

Abstract

Tumor lysis syndrome (TLS) is a fatal complication of chemotherapy treatment. It is rarely seen in the treatment of solid tumors particularly in breast cancer. We presented the case of a chemo-naïve 58-year-old Caucasian woman who developed tumor lysis syndrome (TLS) after a single treatment dose of gemcitabine for metastatic breast cancer. Despite optimal management, the patient clinically deteriorates and is referred to inpatient hospice. Although targeted chemotherapy options have become increasingly effective, physicians should be aware of the rare, yet often fatal complications of TLS. Similarly, physicians should be able to quickly recognize the development of TLS to ensure swift and effective prophylaxis or treatment.

Keywords: chemotherapy; solid tumors; tumor lysis syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Tumor lysis syndrome: prevention and treatment. [Dec;2018 ];https://www.uptodate.com/contents/tumor-lysis-syndrome-prevention-and-tr... 2018
    1. Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report. Baudon C, Duhoux F, Sinapi I, Canon JL. J Med Case Rep. 2016;10:1–4. - PMC - PubMed
    1. Tumor lysis syndrome in solid tumors: an up to date review of the literature. Mirrakhimov A, Ali A, Khan M, Barbaryan A. Rare Tumors. 2014;6:5389. - PMC - PubMed
    1. Tumor lysis syndrome: definition, pathogenesis, clinical manifestations, etiology and risk factors. [Dec;2018 ];https://www.uptodate.com/contents/tumor-lysis-syndrome-definition-pathog... 2018
    1. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. Coiffier B, Altman A, Pui C, Younes A, Cairo MS. J Clin Oncol. 2012;28:708. - PubMed

Publication types

LinkOut - more resources